In tightly regulated sectors like pharmaceuticals, the quality and compliance of raw materials are not negotiable. Pharmaceutical-grade chitosan used in drug delivery systems, wound care, tissue engineering, and medical devices must meet rigorous global standards.
That is why choosing the right chitosan supplier is more than a procurement decision, it is a strategic move to ensure patient safety, pass regulatory audits, and protect long-term product integrity.
At Fresh On Time Seafood, we deliver a traceable, fully documented supply chain that meets international pharmaceutical-grade requirements, positioning us as a certified chitosan supplier trusted by global buyers.
Fresh On Time Seafood, established by Bintarna Tardy in 2004, is a trusted global manufacturer and supplier of premium seafood and chitosan products made from crab shells.
Our sustainable and innovative approach serves a wide range of industries, including food, healthcare, cosmetics, agriculture, and water treatment. We are committed to delivering consistent quality, exceptional service, and reliable solutions to clients worldwide.
What Defines Pharmaceutical-Grade Chitosan? Key Specifications
Pharmaceutical-grade chitosan is not merely about high purity, it is defined by its performance, safety, documentation, and consistency.
While industrial-grade chitosan may be sufficient for applications in textiles or agriculture, pharmaceutical use requires compliance with strict technical and legal specifications.
High Degree of Deacetylation (DDA)
Most pharmaceutical formulations require a DDA of at least 85%, with typical ranges between 85–95%. DDA influences solubility, bioactivity, and interaction with other drug components.
Consistent Molecular Weight and Viscosity
Batch-to-batch consistency in molecular weight and viscosity is essential for reproducibility in drug delivery and medical-grade applications. Any deviation can compromise efficacy.
Low Impurity Profile
Pharma-grade chitosan must contain extremely low levels of impurities, including ash, proteins, heavy metals, and endotoxins. Testing is performed using validated methods such as ICP-OES for metals analysis and LAL assay for endotoxins.
Microbial and Endotoxin Control
Chitosan used in medical products must meet limits for total microbial count and endotoxin levels. Gamma irradiation or aseptic processing may be required.
Full Technical Documentation
Even if the material meets quality specifications, it cannot be used in regulated markets without proper documentation. Each batch must be delivered with a Certificate of Analysis (COA), MSDS, and traceability records.
What is another name for chitosan?
Chitosan is sometimes referred to as deacetylated chitin, since it is derived from chitin found in crustacean shells and fungi. In research and industry, it may also appear under names like chitosan ascorbate, N-sulfated chitosan, or carboxymethyl chitosan, depending on its chemical modifications.
Regulatory Requirements for Pharma Applications
Global regulatory bodies demand full transparency, validation, and traceability from expedient suppliers. A qualified chitosan supplier must adhere to the following regulatory frameworks:
ISO Certifications
Pharma-grade manufacturers are expected to maintain:
- ISO 9001: Quality Management Systems
- ISO 13485: Medical device component manufacturing
- ISO 14001: Environmental Management (preferred by ESG-focused buyers)
GMP and Quality Control
When chitosan is used as a pharmaceutical excipient, companies typically require Good Manufacturing Practice (GMP) or cGMP-aligned standard operating procedures.
Global Market Requirements
Qualified chitosan manufacturers must comply with:
- FDA (21 CFR) guidelines for drug and device components
- EU REACH for chemical safety compliance
- European Pharmacopoeia (Ph. Eur.) or USP standards
- Japanese Pharmaceutical Excipients (JPE) for access to Asia
Documentation Package
A professional chitosan supplier checklist includes:
- Certificate of Analysis (COA)
- Material Safety Data Sheet (MSDS)
- Batch production records
- Origin declarations (species, country)
- Traceability flowchart
- Stability and microbial reports
Evaluating a Supplier: Key Procurement KPIs
Procurement teams in pharmaceutical firms must consider multiple dimensions when choosing a chitosan manufacturer:
| KPI Area | What to Evaluate |
| Documentation Accuracy | COA completeness, third-party validation, MSDS clarity |
| Batch Consistency | Reproducible DDA, viscosity, microbial count |
| Traceability | Full source transparency down to catch or harvest lot |
| Compliance Support | REACH/FDA document assistance |
| Logistics & Delivery | Timely fulfillment, customs documentation readiness |
| Sustainability Metrics | Byproduct sourcing, ESG reports, environmental tracking |
These KPIs support supplier scoring systems during audits or qualification processes.
Our Vertically Integrated Pharmaceutical Chitosan Process
For pharmaceutical applications where material quality, documentation, and chain of custody contribute to overall product development requirements, selecting the right chitosan provider with uncompromising traceability is essential.
We are not only a supplier of Indonesian chitosan material but also one of the few integrated producers in the market capable of scaling laboratory-grade processes to produce high-purity, pharmaceutical-grade biopolymers industrially.
Starting from an ethically sourced raw material to entirely custom formulations and regulatory documentation, we provide a chitosan solution built to meet the high pharmaceutical requirements.
Control & Consistency with Vertically Integrated Manufacturing
Our process of manufacturing is created in such a way that it meets the pharma standards. It all starts upstream: with whole, clean crab shells sourced as byproducts from approved and traceable seafood processors in Indonesia.
Before our production facility, these raw materials undergo strict quality screening.
We handle the full processing pipeline on our own:
- Deproteinization
- Demineralization
- 脱アセチル化
- Drying and milling
- Final QA testing
This full-cycle model ensures absolute purity, performance parameters & traceability. By not procuring from third-party sources or uncertain biomass supplies, we provide our customers with reliable quality and reduced risk of adulteration.
Chitosan Specifications for Pharmaceutical Applications
Chitosan serves as a significant pharmaceutical excipient in various drug product formulations. The material functions as both a processing aid and an active functional ingredient in pharmaceutical applications.
Research has extensively documented chitosan’s biocompatible, biodegradable, and film-forming characteristics across multiple studies.
However, pharmaceutical-grade chitosan must satisfy specific physicochemical and microbiological parameters to ensure regulatory compliance and product safety.
Separating itself from the typical grade chitosans in global trading, we deliver competitive chitosan that matches or overrides global industry standards for performance:
Key Specifications:
- Degree of Deacetylation (DDA): 85–92%
- Viscosity: 50–800 cP (could be adjusted according to client request)
- Ash Content: <1%
- Trace/Heavy Metals: < DL (Pb, Cd, Hg, As)
- Microbial Load: Within USP standards
- MESH SIZE: Special mesh size available upon request
All batches are given a unique production code and have an accompanying batch-specific Certificate of Analysis (COA) that is validated in-house or verified by third-party, accredited labs as needed.
Please note that material specifications alone do not guarantee suitability for specific pharmaceutical applications, additional testing and validation may be required.
Suppliers need to be able to show the performance of these materials as well as compliance needs, which creates a sense of transparency for buyers within pharmaceutical circles.
Regulatory Documentation and Support
When we talk about pharmaceutical-grade chitosan, we do not just mean purity, we are referring to an entire ecosystem of documentation, traceability, and compliance.
Each batch exported is accompanied by a full set of regulatory documents, produced by Fresh On Time Seafood.
Sustainable and Traceable Sourcing
Our operations are built on sustainable and transparent sourcing principles. While many global chitosan suppliers rely on wild-caught aquatic sources and crustaceans, we have developed a different approach.
Our strategy focuses on sourcing crab shells from seafood processors that maintain HACCP certification and comply with environmental permit requirements.
Key sustainability practices include:
- Sustainable fisheries, fishing that is done respectfully and not damaging to the ocean or the environment
- Minimize Chemical Using in Wastewater Treatment Systems
- Optimized process for lower chemical and energy use
So this would differentiate our chitosan as both sustainably and responsibly sourced, and with more pharmaceutical companies striving to achieve ESG or green chemistry targets, it is becoming increasingly relevant.
This sustainable approach ensures that our chitosan meets both the quality and environmental standards that modern pharmaceutical companies require.
Technical & Formulation Support
Our approach extends beyond simple material supply to include comprehensive technical collaboration. Our technical team works directly with your departments to align chitosan specifications with your development objectives and regulatory requirements.
We recognize that chitosan plays critical functional roles in various pharmaceutical applications and formulations. Potential Research Applications :
- Wound dressings and scaffolds
- Controlled drug delivery systems
- Mucoadhesive drug formulations
- Encapsulation and film coatings
We support:
- Requirements of solubility and dispersion of mesh size
- Viscosity Tuning and DDA Based on Formulation Requirements
- Pre-shipment samples for compatibility testing
- Rapid batch documentation and testing certificates
We Build the Future of Biopolymer Pharma Together
Pharmaceutical-quality chitosan needs more than a supplier, it needs a partner with legal vertical integration, proven quality control, comprehensive documentation, and technical support (for real).
We are different by offering:
- Full traceability from collection of the shells to final chitosan
- QA at the Batch Level, Optional third-party validation
- ISO, HACCP compliance, and upcoming GMP standards
- Regulatory readiness for export markets
- Pharma-grade applications featuring adaptable technical support
Our infrastructure is tailored to meet your pharmaceutical requirements for new products in early R&D as well as already commercialized.
Going forward, safer, traceable, and environmentally sustainable excipients will be demanded by the pharmaceutical industry. And chitosan is one of the tools in that toolbox.
Working with Fresh On Time Seafood, you get more than just a supplier of raw materials, you get a companion who concentrates on accuracy, performance, and global obedience.
FAQ
What are the global compliance standards for pharmaceutical-grade chitosan?
Pharmaceutical-grade chitosan must meet ISO and GMP standards, comply with FDA/EU pharmacopeias, maintain strict specs (DD%, viscosity, purity, microbial safety), and provide full batch documentation with traceability.
What level of Degree of Deacetylation (DDA) is typically required for pharmaceutical-grade chitosan?
Most pharmaceutical applications require a DDA between 85–95%, as it affects solubility, bioactivity, and compatibility with drug formulations.
Why is documentation so critical for pharmaceutical-grade chitosan suppliers?
Even if the material meets quality specifications, regulated markets require complete documentation, such as COA, MSDS, and traceability records, to ensure regulatory compliance and audit readiness.